TNF and multiple sclerosis: For example, it is imperative to exclude TBI prior to the commencement of immunosuppressive therapy (e.g. tumor necrosis factor alpha [TNFα] inhibitors) in patients presenting with a multitude of immune-mediated inflammatory disorders, including inflammatory bowel diseases, rheumatological inflammations and multiple sclerosis.